Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Protectionist Economic Policies Create Roadblocks For Foreign Companies In China, Says U.S. Treasury Secretary

This article was originally published in PharmAsia News

Executive Summary

BEIJING - As the U.S. Senate held hearings on the Chinese exchange rate and overall economic policies that are said to be underlying an immense trade imbalance and blocking American businesses from competing freely in China, Treasury Secretary Timothy Geithner outlined an array of new and potential countermeasures
Advertisement

Related Content

China's Delays In Approving Clinical Trials, Poor IPR Block Access To Innovative Drugs - EU Chamber Of Commerce
China's Delays In Approving Clinical Trials, Poor IPR Block Access To Innovative Drugs - EU Chamber Of Commerce
China's Delays In Approving Clinical Trials, Poor IP Protections Block Access To Innovative Drugs - EU Chamber Of Commerce
China's Delays In Approving Clinical Trials, Poor IP Protections Block Access To Innovative Drugs - EU Chamber Of Commerce
Long-term Backer Of Stronger Trade Ties With China, U.S. Senator Warns Of Potential Economic Face-off
Long-term Backer Of Stronger Trade Ties With China, U.S. Senator Warns Of Potential Economic Face-off
European Union Chamber Calls For Market Opening, Equal Access In China; €1 Trillion In WTO Procurement At Stake
U.S. Treasury Secretary, In Beijing Visit, Outlines Varying Goals Of American And Chinese Reforms In Healthcare, Economic Systems
U.S. Treasury Secretary, In Beijing Visit, Outlines Varying Goals Of American And Chinese Reforms In Healthcare, Economic Systems
Counterfeit Drugs Produced In China Still Threaten Chinese, U.S., Global Consumers
Advertisement
UsernamePublicRestriction

Register

SC075971

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel